ALISERTIB for Neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where ALISERTIB was used for Neoplasm.
Most Reported Side Effects for ALISERTIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Neutropenia | 16 | 19.1% | 2 | 1 |
| Dehydration | 12 | 14.3% | 1 | 4 |
| Hyponatraemia | 10 | 11.9% | 0 | 2 |
| Malignant neoplasm progression | 10 | 11.9% | 1 | 0 |
| Toxicity to various agents | 10 | 11.9% | 0 | 0 |
| Anaemia | 9 | 10.7% | 3 | 2 |
| Leukopenia | 9 | 10.7% | 0 | 1 |
| Lymphopenia | 9 | 10.7% | 0 | 2 |
| Mucosal inflammation | 9 | 10.7% | 0 | 2 |
| Febrile neutropenia | 8 | 9.5% | 1 | 2 |
| Fatigue | 7 | 8.3% | 2 | 3 |
| Vomiting | 7 | 8.3% | 1 | 1 |
| Diarrhoea | 6 | 7.1% | 1 | 1 |
| Thrombocytopenia | 6 | 7.1% | 2 | 1 |
| Drug ineffective | 5 | 6.0% | 0 | 0 |
Other Indications for ALISERTIB
Neuroblastoma (14)
Pancreatic carcinoma (11)
Atypical teratoid/rhabdoid tumour of cns (7)
Neoplasm malignant (6)
Other Drugs Used for Neoplasm
BEVACIZUMAB (502)
ATEZOLIZUMAB (404)
CYCLOPHOSPHAMIDE (385)
CARBOPLATIN (283)
PACLITAXEL (267)
NIVOLUMAB (219)
OXALIPLATIN (185)
PEMBROLIZUMAB (173)
LENALIDOMIDE (171)
DOXORUBICIN (150)